Data as of Jan 26
| +2.03 / +3.47%|
The 6 analysts offering 12-month price forecasts for Auspex Pharmaceuticals Inc have a median target of 65.50, with a high estimate of 81.00 and a low estimate of 44.00. The median estimate represents a +8.28% increase from the last price of 60.49.
The current consensus among 6 polled investment analysts is to Buy stock in Auspex Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.